中文

Sector leaders · Company list

ADC Drugs

Covers target discovery, linker and conjugation technology and manufacturing for antibody-drug conjugates, a closely watched field in innovative-drug out-licensing and the upgrading of cancer therapy.

Why these companies

Selection basis

Representative companies are selected from 2025 clinical progress, overseas licensing deals and capacity plans for domestic antibody-drug conjugates. Updated 2026-09-29 · unordered list

Representative companies

ADC Drugs leader list

5 companies

Existing public reports are free to view. Generating a new report and professional valuation are paid features and use one credit each (2 free credits after verifying your email on sign-up).

Sources

Industry and company sources

This page is a research directory. “Representative leader” is not an official designation, a return forecast or trading advice. Valuations and reports may contain errors or outdated information; verify against company filings and authoritative sources.